Encore Pharmaceutical Inc. FDA Record
- Latest inspection NAI · Oct 20, 2008
- No warning letters matched by name
Encore Pharmaceutical Inc. has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Encore Pharmaceutical Inc." is on file.
- Latest inspection
- Oct 20, 2008 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 1 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Encore Pharmaceutical Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Encore Pharmaceutical Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Oct 20, 2008 | S Plainfield, NJ | Drugs | No Action Indicated (NAI) | 2000046949 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 2000046949 | S Plainfield, NJ | 1 | Oct 20, 2008 |
Encore Pharmaceutical Inc. and the FDA: common questions
Has Encore Pharmaceutical Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Encore Pharmaceutical Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Encore Pharmaceutical Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Encore Pharmaceutical Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Encore Pharmaceutical Inc.?
The most recent FDA inspection on file ended Oct 20, 2008 at S Plainfield, NJ and was classified NAI. FDA has 1 inspection of Encore Pharmaceutical Inc. on file.
Need more than this page shows? Ask about Encore Pharmaceutical Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.